Factor V and Thrombotic Disease Description of a Janus-Faced ...

536 Arterioscler Thromb Vasc Biol. April 2002
8. Dahlbäck B. Activated protein C resistance and thrombosis: molecular
mechanisms of hypercoagulable state due to FVR506Q mutation. Semin
Thromb Hemost. 1999;25:273–289.
9. Dahlbäck B. Blood coagulation. Lancet. 2000;355:1627–1632.
10. Martinelli I. Risk factors in venous thromboembolism. Thromb
Haemost. 2001;86:395–403.
11. Tracy PB, Eide LL, Bowie EJ. Radioimmunoassay of factor V in human
plasma and platelets. Blood. 1982;60:59–63.
12. Chesney CM, Pifer D, Colman RW. Subcellular localization and
secretion of factor V from human platelets. Proc Natl Acad Sci U S A.
1981;78:5180–5184.
13. Owen CA Jr, Bowie EJ. Generation of coagulation factors V, XI, and
XII by the isolated rat liver. Haemostasis. 1977;6:205-212.
14. Wilson DB, Salem HH, Mruk JS, Maruyama I, Majerus PW. Biosynthesis
of coagulation factor V by a human hepatocellular carcinoma cell
line. J Clin Invest. 1984;73:654–658.
15. Chiu HC, Schick PK, Colman RW. Biosynthesis of factor V in isolated
guinea pig megakaryocytes. J Clin Invest. 1985;75:339–346.
16. Gewirtz AM, Keefer M, Doshi K, Annamalai AE, Chiu HC, Colman RW.
Biology of human megakaryocyte factor V. Blood. 1986;67:1639–1648.
17. Camire RM, Pollak ES, Kaushansky K, Tracy PB. Secretable human
platelet-derived factor V originates from the plasma pool. Blood. 1998;
92:3035–3041.
18. Kane WH, Ichinose A, Hagen FS, Davie EW. Cloning of cDNAs coding
for the heavy chain region and connecting region of human factor V, a
blood coagulation factor with four types of internal repeats. Biochemistry.
1987;26;6508–6514.
19. Jenny RJ, Pittman DD, Toole JT, Kriz RW, Aldape RA, Hewick MH,
Kaufman RJ, Mann KG. Complete cDNA and derived amino acid
sequence of human factor V. Proc Natl Acad Sci U S A. 1987;84:
4846–4850.
20. Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH,
Vehar GA, Capon DJ, Lawn RM. Characterization of the human factor
VIII gene. Nature. 1984;312:326–330.
21. Kane WH, Davie EW. Blood coagulation factors V and VIII: structural
and functional similarities and their relationship to hemorrhagic and
thrombotic disorders. Blood. 1988;71:539–555.
22. Koschinsky ML, Funk WD, van Oost BA, MacGillivray RT. Complete
cDNA sequence of human preceruloplasmin. Proc Natl Acad Sci U S A.
1986;83:5086–5090.
23. Church WR, Jernigan RL, Toole JT, Hewick RM, Knopf J, Knutson GJ,
Nesheim ME, Mann KG, Fass DN. Coagulation factors V and VIII and
ceruloplasmin constitute a family of structural related proteins. Proc
Natl Acad Sci U S A. 1984;81:6934–6937.
24. Pellequer JL, Gale AJ, Getzoff ED, Griffin JH. Three-dimensional
model of coagulation factor Va bound to activated protein C. Thromb
Haemost. 2001;84:849–857.
25. Villoutreix BO, Dahlback B. Structural investigation of the A domains
of human blood coagulation factor V by molecular modeling. Protein
Sci. 1998;7:1317–1325.
26. Villoutreix B, Bucher P, Hofmann K, Baumgartner S, Dahlback B.
Molecular models for the two discoidin domains of human blood coagulation
factor V. J Mol Model. 1998;4:268–275.
27. Macedo-Ribeiro S, Bode W, Huber R, Quinn-Allen MA, Kim SW, Ortel
TL, Bourenkov GP, Bartunik HD, Stubbs MT, Kane WH, Fuentes-Prior
P. Crystal structures of the membrane-binding C2 domain of human
coagulation factor V. Nature. 1999;402:434–439.
28. Nicolaes GAF, Villoutreix BO, DahlbackB. Mutations in a potential
phospholipid binding loop in the C2 domain of factor V affecting the
assembly of the prothrombinase complex. Blood Coagul Fibrinolysis.
2001;11:89–100.
29. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine factor
V and factor Va to the activity of the prothrombinase. J Biol Chem.
1979;254:10952–10962.
30. Monkovic D, Tracy P. Activation of human factor V by factor Xa and
thrombin. Biochemistry. 1990;29:1118–1128.
31. Suzuki K, Dahlbäck B, Stenflo J. Thrombin-catalyzed activation of
human coagulation factor V. J Biol Chem. 1982;257:6556–6564.
32. Tans G, Nicolaes GA, Thomassen MC, Hemker HC, van Zonneveld AJ,
Pannekoek H, Rosing J. Activation of human factor V by meizothrombin.
J Biol Chem. 1994;269:15969–15972.
33. Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC. The
role of phospholipids and factor Va in the prothrombinase complex.
J Biol Chem. 1980;255:274–283.
34. Cui J, O’Shea KS, Purkayastha A, Saunders TL, Ginsburg D. Fatal
haemorrhage and incomplete block to embryogenesis in mice lacking
coagulation factor V. Nature. 1996;384:66–68.
35. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of
human factor V and human factor Va by activated protein C. J Biol
Chem. 1994;269:31869–31880.
36. Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi
K, Schwarz HP, Rosing J. Peptide bond cleavages and loss of functional
activity during inactivation of factor Va and factor VaR506Q by activated
protein. J Biol Chem. 1995;270:21158–21166.
37. Rosing J, Hoekema L, Nicolaes GA, Thomassen MC, Hemker HC,
Varadi K, Schwarz HP, Tans G. Effects of protein S and factor Xa on
peptide bond cleavages during inactivation of factor Va and factor
Va R506Q by activated protein C. J Biol Chem. 1995;270:27852–27858.
38. Arnljots B, Dahlback B. Protein S as an in vivo cofactor to activated
protein C in prevention of microarterial thrombosis in rabbits. J Clin
Invest. 1995;95:1987–1993.
39. Arnljots B, Dahlback B. Antithrombotic effects of activated protein C
and protein S in a rabbit model of microarterial thrombosis. Arterioscler
Thromb Vasc Biol. 1995;15:937–941.
40. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov
V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, et al.
Inherited thrombophilia. Thromb Haemost. 1996;76:824–834.
41. Kalafatis M, Mann KG. The role of the membrane in the inactivation of
factor Va by plasmin: amino acid region 307–348 of factor V plays a
critical role in factor Va cofactor function. J Biol Chem. 2001;276:
18614–18623.
42. Dahlbäck B. Thrombophilia: the discovery of activated protein C
resistance. Adv Genet. 1995;33:135–175.
43. Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is
corrected by anticoagulant cofactor activity found to be a property of
factor V. Proc Natl Acad Sci U S A. 1994;91:1396–1400.
44. Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to
activated protein C in degradation of factor VIIIa. J Biol Chem. 1994;
269:18735–18738.
45. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De
Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation
factor V associated with resistance to activated protein C. Nature.
1994;369:64–67.
46. Greengard JS, Sun X, Xu X, Fernández JA, Griffin JH, Evatt B. Activated
protein C resistance caused by Arg506Gln mutation in factor Va.
Lancet. 1994;343:1361–1362.
47. Voorberg J, Roelse JC, Koopman R, Büller HR, Berends F, Ten Cate
JW, Mertens K, Van Mourik JA. Association of idiopathic venous
thromboembolism with single point-mutation at Arg 506 of factor V.
Lancet. 1994;343:1535–1536.
48. Zoller B, Dahlback B. Linkage between inherited resistance to activated
protein C and factor V gene mutation in venous thrombosis. Lancet.
1994;343:1536–1538.
49. Rees DC, Cox MJ, Clegg JB. World distribution of factor V Leiden.
Lancet. 1995;346:1133–1134.
50. Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner
B, Eldor A, Seligsohn U. A single genetic origin for a common Caucasian
risk factor for venous thrombosis. Blood. 1997;89:397–402.
51. Varadi K, Rosing J, Tans G, Schwarz HP. Influence of factor V and
factor Va on APC-induced cleavage of human factor VIII. Thromb
Haemost. 1995;73:730–731. Letter.
52. Váradi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. Factor V
enhances the cofactor function of protein S in the APC-mediated inactivation
of factor VIII: influence of the factor VR506Q mutation.
Thromb Haemost. 1996;76:208-214.
53. Lu DS, Kalafatis M, Mann KG, Long GL. Comparison of activated
protein C/protein S-mediated inactivation of human factor VIII and
factor V. Blood. 1996;87:4708–4717.
54. Thorelli E, Kaufman RJ, Dahlback B. Cleavage of factor V at Arg 506
by activated protein C and the expression of anticoagulant activity of
factor V. Blood. 1999;93:2552–2558.
55. Nicolaes GAF, Thomassen MCLGD, Tans G, Rosing J, Hemker HC.
Effect of activated protein C on thrombin generation and on the
thrombin potential in plasma of normal and APC resistant individuals.
Blood Coagul Fibrinolysis. 1997;8:28–38.
56. Thorelli E, Kaufman RJ, Dahlback B. The C-terminal region of the
factor V B-domain is crucial for the anticoagulant activity of factor V.
J Biol Chem. 1998;273:16140–16145.
Downloaded from
http://atvb.ahajournals.org/ by guest on October 23, 2012